HER-2 Positive Advanced Gastric Cancer
2 clinical trials · Condition
◉ Watch HER-2 Positive Advanced Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer (NCT01746771) | Hanmi Pharmaceutical Company Limited | 2012-11-01 |
| A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer (NCT01736410) | National Cancer Centre, Singapore | 2010-05-01 |
Track HER-2 Positive Advanced Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.